glp-1 news november 3 2025 Survey: 37.5% of People Stop GLP-1s after Just Months Despite FDA ruling, compounded GLP-1s

Here is the real state of the evidence: Tesamorelin has genuine human RCT data

The practical rule: use a U-100 syringe for semaglutide, tirzepatide, and similar compounded peptides reconstituted at 1 mg/ml

They can tailor your protocol to your specific goals, biomarkers, and lifestyle

(Houston, TX, USA)

The ability to select only passing results is a hallmark of "Testing into Compliance." Risk to Patient Safety: The warning letter links "poor aseptic technique" with "data integrity lapses".15 The FDA required a risk assessment of "risks to patients caused by the release of drugs affected by a lapse of data integrity." This connects the abstract concept of "computer controls" to the concrete reality of "sterile" drugs potentially being contaminated due to manipulated production data

Strategies aimed to increase cytosol GSH (e.g., NAC) may not be an optimal approach for boosting mGSH and therefore for treatment of SH or AD, as it would result in mainly increasing cytosol GSH without replenishing mGSH levels A new approach has been exploited recently in several contexts by the development of a series of cationic antioxidants targeted to mitochondria, including derivatives of the endogenous antioxidants ubiquinol (MitoQ), alpha-tocopherol (MitoVit E), and of the synthetic spin trap PBN (MitoPBN